Morphology and surface properties of high strength siloxane poly(urethane-urea)s developed for heart valve application.

biostable linked-macrodiol morphology poly(urethane-urea) polydimethylsiloxane

Journal

Journal of biomedical materials research. Part B, Applied biomaterials
ISSN: 1552-4981
Titre abrégé: J Biomed Mater Res B Appl Biomater
Pays: United States
ID NLM: 101234238

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 11 2017
revised: 28 01 2018
accepted: 12 02 2018
pubmed: 6 3 2018
medline: 2 4 2020
entrez: 6 3 2018
Statut: ppublish

Résumé

A series of siloxane poly(urethane-urea) (SiPUU) were developed by incorporating a macrodiol linked with a diisocyanate to enhance mixing of hard and soft segments (SS). The effect of this modification on morphology, surface properties, surface elemental composition, and creep resistance was investigated. The linked macrodiol was prepared by reacting α,ω-bis(6-hydroxyethoxypropyl) poly(dimethylsiloxane)(PDMS) or poly(hexamethylene oxide) (PHMO) with either 4,4'-methylenediphenyl diisocyanate (MDI), hexamethylene diisocyanate (HDI), or isophorone diisocyanate (IPDI). SiPUU with PHMO-MDI-PHMO and PHMO-IPDI-PHMO linked macrodiols showed enhanced creep resistance and recovery when compared with a commercial biostable polyurethane, Elast-Eon™ 2A. Small and wide-angle X-ray scattering data were consistent with significant increase of hydrogen bonding between hard and SS with linked-macrodiols, which improved SiPUU's tensile stress and tear strengths. These SiPUU were hydrophobic with contact angle higher than 101° and they had low water uptake (0.7%·w/w of dry mass). They also had much higher siloxane concentration on the surface compared to that in the bulk. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 107B: 112-121, 2019.

Identifiants

pubmed: 29504237
doi: 10.1002/jbm.b.34101
doi:

Substances chimiques

Polyurethanes 0
Siloxanes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-121

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Loshini S Dandeniyage (LS)

School of Science, RMIT University, Melbourne, City campus, Victoria, 3000, Australia.
CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Raju Adhikari (R)

CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Mark Bown (M)

CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Robert Shanks (R)

School of Science, RMIT University, Melbourne, City campus, Victoria, 3000, Australia.

Benu Adhikari (B)

School of Science, RMIT University, Melbourne, City campus, Victoria, 3000, Australia.
CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Christopher D Easton (CD)

CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Thomas R Gengenbach (TR)

CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

David Cookson (D)

Australian Synchrotron ANSTO, Clayton, Victoria, 3168, Australia.

Pathiraja A Gunatillake (PA)

CSIRO Manufacturing, Clayton, Victoria, 3168, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH